Showing results (11-20 of 44) with videos related to
Sort By:
Pageof 5
The Annals of Thoracic Surgery|March 22, 2008
Chronic expanding hematoma in sternum resected 5 years after median sternotomySusumu Kunisawa, Shinji Kosaka, Tadashi Matsukura, et al.The Tohoku Journal of Experimental Medicine|June 19, 2024
Disaster Pharmacists' Support and Challenges Faced by Hospital Pharmacy Departments in the Disaster Response for the 2024 Noto Peninsula EarthquakeTatsuya Tai, Masahiro Watanabe, Sayaka Yamashita, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 22, 2023
Evaluation of the meropenem dosage and administration schedule in patients with bacteremia initial therapyTatsuya Tai, Takaaki Yamamoto, Kazunori Yamaguchi, et al.Journal of Chemotherapy (Florence, Italy)|January 21, 2020
Relationship between epidermal growth factor receptor mutations and skin rash in non-small cell lung cancer patientsHiroaki Tanaka, Kimiko Atagi, Takakiyo Tatsumichi, et al.Biological & Pharmaceutical Bulletin|June 3, 2014
Developing population pharmacokinetic parameters for high-dose methotrexate therapy: implication of correlations among developed parameters for individual parameter estimation using the Bayesian least-squares methodMasahiro Watanabe, Noriyasu Fukuoka, Toshiki Takeuchi, et al.The Journal of Thoracic and Cardiovascular Surgery|September 26, 2018
Effect of virtual-assisted lung mapping in acquisition of surgical margins in sublobar lung resectionMasaaki Sato, Masashi Kobayashi, Fumitsugu Kojima, et al.Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|July 31, 2026
Association between dentists' awareness of antimicrobial resistance and selection of oral third-generation cephalosporins: a cross-sectional studyTatsuya Tai, Takahiro Motoki, Naohiro Kurokawa, et al.The Journal of Medical Investigation : JMI|May 17, 2021
Relationship between Epidermal Growth Factor Receptor Mutations and Adverse Events in Non-Small Cell Lung Cancer Patients treated with AfatinibSayaka Yamashita, Hiroaki Tanaka, Takakiyo Tatsumichi, et al.Biological & Pharmaceutical Bulletin|April 3, 2018
Hypertension and Proteinuria as Predictive Factors of Effects of Bevacizumab on Advanced Breast Cancer in JapanHiroaki Tanaka, Koichi Takahashi, Kazunori Yamaguchi, et al.Journal of Clinical Pharmacy and Therapeutics|October 12, 2020
Uterine sarcoma with posterior reversible encephalopathy syndrome associated with pazopanibTakakiyo Tatsumichi, Hiroaki Tanaka, Tomoya Okazaki, et al.Pageof 5